The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that first emerged in
late 2019 is responsible for a pandemic of severe respiratory illness. People infected with this …

Background Some observational studies have reported that transfusion of red-cell units that
have been stored for more than 2 to 3 weeks is associated with serious, even fatal, adverse …

Background Influenza causes substantial morbidity and mortality despite available treatments.
Anecdotal reports suggest that plasma with high antibody titres to influenza might be of …

Thrombocytopenia is a common complication of Human Immunodeficiency Virus (HIV) infection.
With advanced HIV disease, the presence of both thrombocytopenia and schistocytosis …

The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory
syndrome-related coronavirus 2 (SARS-CoV-2) has now caused over 2 million deaths …

Sickle cell disease (SCD) is associated with chronic activation of coagulation and an increased
risk of venous thromboembolism. Erythrocyte sickling, the primary pathologic event in …

Red blood cell (RBC) alloimmunization is a significant clinical complication of sickle cell
disease (SCD). It can lead to difficulty with cross‐matching for future transfusions and may …

Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is characterized by recurring
episodes of thrombotic microangiopathy, causing ischemic organ impairment. Black …

Background Chimeric antigen receptor T (CAR‐T) cell successes have encouraged continued
clinical study. Apheresis collection of starting material for CAR‐T cell therapy product …

Previous work from our group and others has shown that patients with breast cancer can
generate a T cell response against specific human epidermal growth factor 2 (HER2) epitopes. …